Metropolitan Life Insurance Company (MetLife)’s Asensus Surgical, Inc. ASXC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-28,817	Closed	-$32K	–	2744
2021 Q4	$32K	Sell	28,817 -15,503	-35%	-$24K	﹤0.01%	2732
2021 Q3	$82K	Sell	44,320 -24,002	-35%	-$53.9K	﹤0.01%	2633
2021 Q2	$217K	Buy	+68,322	New	+$171K	﹤0.01%	2090
2019 Q3	–	Sell	-4,229	Closed	-$74.8K	–	2634
2019 Q2	$74.8K	Hold	4,229	–	–	﹤0.01%	2441
2019 Q1	$131K	Buy	4,229 +100	+2%	+$3.35K	﹤0.01%	2161
2018 Q4	$121K	Hold	4,129	–	–	﹤0.01%	2144
2018 Q3	$311K	Hold	4,129	–	–	0.01%	1695
2018 Q2	$234K	Buy	+4,129	New	+$150K	﹤0.01%	1840

Other funds holding ASXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ASXC Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Asensus Surgical, Inc. (ASXC) in Q1 2022, closing a stake of 28,817 shares — an estimated $32K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ASXC in Q2 2018 and held it in 8 quarters. The position peaked at $311K in Q3 2018. 115 funds tracked by Wall St. Rank hold ASXC as of Q1 2022.

Metropolitan Life Insurance Company (MetLife) reported no remaining Asensus Surgical, Inc. position as of Q1 2022 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 28,817 Asensus Surgical, Inc. shares in Q1 2022, an estimated $32K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Asensus Surgical, Inc. in Q2 2018 and held it in 8 quarters.
Metropolitan Life Insurance Company (MetLife)'s Asensus Surgical, Inc. position peaked at $311K in Q3 2018.
115 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.